Inova proton therapy shows survival benefit in landmark phase III trial for head and neck cancer patients

Proton therapy suite at Inova Mather Proton Therapy Center

FAIRFAX, VA – A new study published today in The Lancet demonstrates a significant survival benefit for patients with oropharyngeal cancers of the head and neck treated with proton therapy compared with traditional radiation therapy (photon therapy). Inova Schar Cancer and The Mather Proton Therapy Center, home to Northern Virginia’s only proton therapy center and…

Read More

Promising results from the PATHFINDER II cancer screening study

Female scientist looking at male colleague conducting cancer research. Clinical researches are working in laboratory.

Rebecca Kaltman, MD is a board-certified hematologist oncologist. She serves as the Medical Director of the Inova Saville Cancer Screening and Prevention Center. At Inova Schar Cancer, we’re excited to share encouraging news from a major national research study called PATHFINDER II. This study is helping shape the future of cancer screening – and it’s bringing…

Read More

“Should Runners Be Worried About Colon Cancer?,” Runner’s World, September 19, 2025

Marathon running in the light of evening

While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening…

Read More

Groundbreaking Inova study finds potential link between long-distance running and colon cancer

Athletes running down hill on mountain trail. Men and women running in cross country marathon race.

Fairfax, VA – A groundbreaking new study led by Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, has revealed a potential link between extreme endurance exercise and increased risk of advanced colon cancer in younger adults, raising new questions about screening for high-performance athletes.…

Read More

Suzuki Receives 2023 AstraZeneca Lung Cancer Research Award

The Board of Directors of The Thoracic Surgery Foundation has named Kei Suzuki, MD, the recipient of the 2023 AstraZeneca Lung Cancer Research Award. Suzuki was recognized for his project, “Single-cell RNA sequence profiling of tumor-immune microenvironment for precision therapy in resectable lung cancer.”  “This funding is crucial to take the research to the next…

Read More

Inova Saville Cancer Screening and Prevention Center Joins an International Effort to Fight Pancreatic Cancer

Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology.  We know the realities of pancreatic cancer. It is a disease that caused 48,220 deaths in the United States in 2021, and 466,003 worldwide in 2020. It…

Read More

Research Finds New Options For Women with Stage IV Breast Cancer

inova logo

Breakthrough Brings Physicians Closer to Developing Customized Cancer Treatments Falls Church, VA  – (May 29, 2009) — Researchers at Inova Fairfax Hospital led a study that gives Stage IV breast cancer patients new treatment options. This breakthrough brings physicians one step closer to developing customized and targeted cancer treatments for their patients. The results of the…

Read More

Inova Fairfax Hospital for Children Receives $25,000 Grant for Cancer Research

inova logo

St. Baldrick’s Foundation Chooses Hospital for Local Support; Hospital’s Doctor to Become “Shavee” Falls Church, VA – (February 14, 2007) — Inova Fairfax Hospital for Children will accept a $25,000 grant for childhood cancer research from the St. Baldrick’s Foundation, a group that raises money solely for childhood cancer research in an unusual way – by shaving…

Read More